Improved quality of life after XeCl excimer transmyocardial laser revascularization: Results of a randomized trial

Huikeshoven, Menno; Sloot, Jos A.P. van der; Tukkie, Raymond; Gemert, Martin J. C. van; Tijssen, Jan G.P.; Beek, Hans van

doi:10.1002/lsm.10189

Cited by 9 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The XeCl excimer laser has been used in cardiology for transmyocardial laser revascularization and in dentistry for the ablation of dentine. 5,6 In dermatology, the excimer laser was initially developed for the treatment of localized psoriasis to limit the adverse effects of chronic UVB exposure from conventional phototherapy.…”

mentioning

confidence: 99%

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Goldberg

Marmur

SCHMULTS

et al. 2006

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Goldberg

Marmur

SCHMULTS

et al. 2006

Dermatologic Surgery

View full text Add to dashboard Cite

show abstract

“…5,6 In dermatology, the excimer laser was initially developed for the treatment of localized psoriasis to limit the adverse effects of chronic UVB exposure from conventional phototherapy. Laser energy is delivered through a fused silica fiber to a handpiece with variable fluences between 100 and 2,100 mjoules/cm 2 .…”

mentioning

confidence: 99%

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Goldberg

Marmur

SCHMULTS

et al. 2005

Dermatologic Surgery

View full text Add to dashboard Cite

BACKGROUND. Lasers and light sources emitting ultraviolet B (UVB) irradiation have been shown to repigment striae distensae.OBJECTIVE. The purpose of this study was to analyze the histologic and ultrastuctural changes seen after UVB laser-or light source-induced repigmentation of striae distensae.METHODS. Ten subjects with hypopigmented striae were selected. Five subjects were treated with an XeCl excimer UVB laser, and five subjects were treated with a UVB light device. Six months after the final treatment, the biopsies were evaluated for both standard and electron microscopic changes in melanocytes. RESULTS. Analyses of biopsied skin after treatment with both the UVB laser and light source showed increased melanin content, hypertrophy of melanocytes, and an increase in the number of melanocytes in all patients.CONCLUSIONS. Repigmentation of striae distensae with either a UVB laser or light source is due to an increase in melanin pigment, hypertrophy of melanocytes, and an increase in melanocytes. Figure 4. Electron microscopy 6 months after treatment showing an increase in the number and size of melanocytes. (Arrows indicate a subset of the most prominent melanocytes in this section.)

show abstract

Transmyocardial laser revascularization versus medical therapy for refractory angina

Briones¹,

Lacalle-Remigio²,

Marin³

2009

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Improved quality of life after XeCl excimer transmyocardial laser revascularization: Results of a randomized trial

Abstract: QOL significantly improved after XeCl excimer TMLR compared to medication. These results are similar to reported improvements in QOL after CO(2) and Ho:YAG TMLR.

Cited by 9 publications

References 19 publications

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Histologic and Ultrastructural Analysis of Ultraviolet B Laser and Light Source Treatment of Leukoderma in Striae Distensae

Transmyocardial laser revascularization versus medical therapy for refractory angina

Contact Info

Product

Resources

About